Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Cancer Res. 2021 Jan 12;81(11):2943–2955. doi: 10.1158/0008-5472.CAN-20-2874

Fig. 7.

Fig. 7

STIM1 acts as rheostat balancing between ATF4 and NFAT-dependent transcriptional programs. (A) Scheme depicting the amplification of RRM1 and STIM1 upon gemcitabine resistance. While the upregulation of RRM1 drives gemcitabine resistance, increased STIM1 levels elicit a calcium signaling shift, leading to a dampened ER stress response and an aberrant NFAT activation.